Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_2
1
25%
Ph not_applicable
1
25%
Ph phase_4
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus

NCT05051475
completedphase_2

Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia

NCT01360541
completedphase_4

Radiofrequency Ablation for Malignant Biliary Obstruction

NCT01758341
unknownphase_1

Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice

NCT01275768

Clinical Trials (4)

Showing 4 of 4 trials
NCT05051475Not Applicable

Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus

Completed
NCT01360541Phase 2

Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia

Completed
NCT01758341Phase 4

Radiofrequency Ablation for Malignant Biliary Obstruction

Completed
NCT01275768Phase 1

Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4